Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Morphosys Ag ADR (MPSYY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.73
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.1800 +10.92%
on 04/26/18
27.9300 unch
on 05/21/18
+1.3200 (+4.96%)
since 04/20/18
3-Month
23.5000 +18.85%
on 04/05/18
27.9300 unch
on 05/21/18
+4.7850 (+20.67%)
since 02/16/18
52-Week
16.4200 +70.10%
on 08/21/17
27.9300 unch
on 05/21/18
+11.0400 (+65.36%)
since 05/19/17

Most Recent Stories

More News
MorphoSys Announces that its Licensee Janssen has Expanded Clinical Development of Guselkumab (Tremfya(R)) into Ulcerative Colitis

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / January 17, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) announced today that its licensee Janssen Research & Development, LLC...

MOR : 23.43 (-2.46%)
MPSYY : 27.9300 (+0.87%)
MPSYF : 90.7500 (-11.42%)
MorphoSys Announces Presentation of Clinical Data on Proprietary Blood Cancer Programs at Upcoming EHA 2018 Conference

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / May 17, 2018 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY; NASDAQ: MOR) today announced the publication of two abstracts on its proprietary...

MPSYY : 27.9300 (+0.87%)
MorphoSys AG Reports First Quarter 2018 Results

MOR : 23.43 (-2.46%)
MPSYY : 27.9300 (+0.87%)
MorphoSys and Galapagos Announce Initiation of the IGUANA Phase 2 Clinical Trial with MOR106 in Atopic Dermatitis Patients

PLANEGG and MUNICH, GERMANY and MECHELEN, BELGIUM / ACCESSWIRE / May 1, 2018 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR; OTC: MPSYY) and Galapagos NV (GLPG) announced today that...

MOR : 23.43 (-2.46%)
MPSYY : 27.9300 (+0.87%)
MorphoSys Announces Approval of Tremfya(R) (Guselkumab) in South Korea

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / April 26, 2018 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY; NASDAQ: MOR) announced today that an affiliate of its licensee, Janssen...

MPSYY : 27.9300 (+0.87%)
MorphoSys to Host Q1 2018 Conference Call on May 3, 2018

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / April 25, 2018 / MorphoSys AG (FSE: MOR) (XETRA: MOR) (OTC PINK: MPSYY) will publish its first three months' 2018 results on May 2nd, 2018 at 10:00 p.m. CEST (4 p.m....

MOR : 23.43 (-2.46%)
MPSYY : 27.9300 (+0.87%)
MorphoSys AG: Updated Corporate Calendar 2018

Please note MorphoSys's updated financial reporting dates for the remainder of 2018. After the successful listing at Nasdaq, the reporting dates have been updated as follows, in order to make the information...

MPSYY : 27.9300 (+0.87%)
Nasdaq Welcomes MorphoSys AG (Nasdaq: MOR) to The Nasdaq Stock Market

MorphoSys AG (Nasdaq:MOR), a late-stage biopharmaceutical company devoted to the development of innovative and differentiated therapies for patients suffering from serious diseases, visited the Nasdaq...

MOR : 23.43 (-2.46%)
MPSYY : 27.9300 (+0.87%)
NDAQ : 84.35 (+1.19%)
MorphoSys Resolves a Capital Increase to Implement the Offering of 8,300,000 American Depositary Shares (ADS) in the United States

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / April 17, 2018 / (XETRA: MOR; FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY) announced today that its Management Board, with the approval of the Supervisory...

MPSYY : 27.9300 (+0.87%)
Ad hoc: MorphoSys Announces Launch of American Depositary Shares (ADS) Offering in the United States

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / April 9, 2018 / MorphoSys AG (FSE: MOR) (XETRA: MOR) (OTC PINK: MPSYY) announced today that it has commenced an initial public offering in the United States of up...

MOR : 23.43 (-2.46%)
MPSYY : 27.9300 (+0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MPSYY with:

Key Turning Points

2nd Resistance Point 27.9300
1st Resistance Point 27.9300
Last Price 27.9300
1st Support Level 27.9300
2nd Support Level 27.9300

See More

52-Week High 27.9300
Last Price 27.9300
Fibonacci 61.8% 23.5332
Fibonacci 50% 22.1750
Fibonacci 38.2% 20.8168
52-Week Low 16.4200

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar